spacer
The Healthcare Sales & Marketing Network celebrates 20 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Biopharmaceuticals

 HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 10 Dec 2018
Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Dec 2018
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 10 Dec 2018
Rockwell Medical, Inc. Appoints New Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Dec 2018
CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Dec 2018
Akero Therapeutics Appoints Mark Iwicki to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Dec 2018
MiMedx Announces Leadership Changes And Promotions
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Dec 2018
MiMedx Announces Organizational Realignment Program
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Dec 2018
Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Dec 2018
EUSA Pharma Appoints Jeffrey S. Hackman as President US Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Dec 2018
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid(R) SoluTab Delayed-Release Orally Disintegrating Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2018
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Dec 2018
Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 Nov 2018
AbbVie Announces HUMIRA(R) (adalimumab) Global Patent License with Pfizer
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 29 Nov 2018
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Nov 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Nov 2018
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Nov 2018
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Nov 2018
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Nov 2018
Perrigo Launches Its AB Rated Generic Version of Solaraze(R) Gel 3%
Biopharmaceuticals Generics Dermatology Product Launch
 HSMN NewsFeed - 26 Nov 2018
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Nov 2018
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Nov 2018
Allergan Makes New Appointments to Finance Leadership Team
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Nov 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Nov 2018
FDA Approves Gamifant(R) (emapalumab), the First and Only Treatment for Primary Haemophagocytic Lymphohistiocytosis (HLH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2018
Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 19 Nov 2018
FDA Approves AEMCOLO(TM) (rifamycin), the First Antibiotic Approved for the Treatment of Travelers' Diarrhea in Over a Decade
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2018
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2018
Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 14 Nov 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2018
Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Nov 2018
HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Nov 2018
Collidion Announces Settlement of Sonoma Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Nov 2018
Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Nov 2018
AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset
Biopharmaceuticals Diagnostics
 HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Nov 2018
OncoSec Appoints Robert Ward to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2018
Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Nov 2018
Cumberland Pharmaceuticals To Acquire VIBATIV(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Nov 2018
Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2018
EMA Validates and Grants Accelerated Assessment of Marketing Authorization Application for Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2018
Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 1 Nov 2018
FDA's Center for Devices and Radiological Health and Center for Drug Evaluation and Research on agency's warning to consumers about genetic tests that claim to predict patients' responses to specific medications
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 1 Nov 2018
Chris Cargill Appointed Executive Vice President and Chief Financial Officer of Sosei
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2018
Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Nov 2018
AbbVie Receives European Commission Approval of VENCLYXTO(R) (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Oct 2018
Shavit Capital Completes $100 Million Investment Round for Its Fifth Fund
Biopharmaceuticals Devices Venture Capital
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 30 Oct 2018
G3 Pharmaceuticals Signs Exclusive License and Option Agreement for Treating Diastolic Heart Failure (HFpEF) by Inhibiting Galectin-3
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 29 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Kerydin(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Oct 2018
Pneuma Respiratory, Inc. Announces J. Knox Singleton Joins the Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Narcan(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 25 Oct 2018
FogPharma Appoints Dr. Barbara Weber to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2018
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Oct 2018
EpiVax Oncology Appoints Dominique Bridon as Chief Technology Officer and Dan Adams to the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Oct 2018
Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Biopharmaceuticals Generics Oncology Regulatory
 HSMN NewsFeed - 18 Oct 2018
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Fresenius Kabi
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 17 Oct 2018
Adam Hacker, PhD Joins Autolus as Senior Vice President for Regulatory Affairs and Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Oct 2018
Akero Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2018
AbbVie Announces Supplemental New Drug Application Accepted for Priority Review by U.S. FDA for IMBRUVICA(R) (ibrutinib) in Combination with Obinutuzumab (GAZYVA(R)) for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
Older Biopharmaceuticals stories   Return to NewsFeed  
RepFinder 2 - Find Great Medical Independent Sales Reps without recruiter fees.
RepFinder 2 - available on the Apple App Store for iPhone and iPad.